G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
G1T48（一种口服选择性雌激素受体降解剂）和 CDK4/6 抑制剂 lerociclib 可抑制内分泌抗性乳腺癌动物模型中的肿瘤生长
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-020-05575-9
Kaitlyn J Andreano, Suzanne E Wardell, Jennifer G Baker, Taylor K Desautels, Robert Baldi, Christina A Chao, Kendall A Heetderks, Yeeun Bae, Rui Xiong, Debra A Tonetti, Lauren M Gutgesell, Jiong Zhao, Jessica A Sorrentino, Delita A Thompson, John E Bisi, Jay C Strum, Gregory R J Thatcher, John D Nor
